Federal award
ORTHO CLINICAL DIAGNOSTICS K.K.
HT941023P0003
Contract
Obligated and Ceiling
- Obligated (net)
- $3,342,980.26
- Ceiling (potential value, not spending)
- $4,853,611.65
- Current value
- $3,342,980.26
- Gross positive obligations
- $3,355,434.57
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO CLINICAL DIAGNOSTICS K.K. · E35NFBSEY3X4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ORTHO CLINICAL DIAGNOSTICS K.K. · E35NFBSEY3X4
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
- PIID
- HT941023P0003
- Award type code
- B
- Actions
- 16 · May 12, 2023 to May 4, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History16
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 4, 2026 | FY2026 | P00015 | W | $0.00 | — |
| Mar 30, 2026 | FY2026 | P00014 | C | $681,203.00 | — |
| Dec 17, 2025 | FY2026 | P00013 | B | $519,338.95 | — |
| Oct 31, 2025 | FY2026 | P00012 | B | $0.00 | — |
| Sep 11, 2025 | FY2025 | P00011 | G | $0.00 | — |
| May 1, 2025 | FY2025 | P00010 | B | −$914.78 | — |
| Apr 2, 2025 | FY2025 | P00009 | B | $477,316.33 | — |
| Jan 30, 2025 | FY2025 | P00008 | B | $211,229.48 | — |
| Nov 19, 2024 | FY2025 | P00007 | B | $213,452.29 | — |
| Sep 24, 2024 | FY2024 | P00006 | B | $0.00 | — |
| Apr 23, 2024 | FY2024 | P00005 | B | $58,106.27 | — |
| Mar 27, 2024 | FY2024 | P00004 | B | −$10,991.65 | — |
| Jan 22, 2024 | FY2024 | P00003 | B | −$547.88 | — |
| Nov 20, 2023 | FY2024 | P00002 | C | $944,683.95 | — |
| Aug 15, 2023 | FY2023 | P00001 | B | $58,470.88 | — |
| May 12, 2023 | FY2023 | 0 | — | $191,633.42 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.